Jonathan Javitt - Chairman and Chief Scientist, Director, 10%+ Owner at NRX Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chairman and Chief Scientist, Director, 10%+ Owner
Stock Symbol
NRXP, NRXPW on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Jonathan Javitt - trading volume in the past year for NRX Pharmaceuticals, Inc.

Holdings reported by Jonathan Javitt for NRX Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.26M $1.47M $1.17 Dec 17, 2024 By the Jonathan Javitt Living Trust
Common Stock 142K $166K $1.17 Dec 17, 2024 By the Javitt 2012 Irrevocable Dynasty Trust
Common Stock 84.6K $99K $1.17 Dec 17, 2024 Direct
Common Stock 30K $35.1K $1.17 Dec 17, 2024 By the Jonathan Javitt Donor Advised Fund
Stock Option (right to buy) 125K Apr 9, 2025 Direct Common Stock

Transactions reported by Jonathan Javitt for NRX Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.